急诊科对III级和IV级肥胖患者心房颤动或心房扑动进行心脏电复律安全有效
该回顾性图表审查纳入78例BMI>35的III/IV级肥胖急诊房颤或房扑患者,接受急诊直流电心脏电复律。平均体重117.6 kg,平均BMI 39.9 kg/m²。电复律成功72例(92.3%),58例(74.5%)从急诊出院。镇静以丙泊酚为主(中位剂量0.64 mg/kg,单用72例),无患者需气管插管,4例(5.1%)需球囊面罩通气,11例(14%)出现收缩压一过性低于90 mmHg,仅见于使用丙泊酚者,低血压组无神经或心脏后遗症。作者结论为急诊电复律安全有效。
要点
- 78例BMI>35的III/IV级肥胖急诊房颤/房扑患者行直流电心脏电复律,成功72例(92.3%),58例(74.5%)从急诊出院。
- 镇静以丙泊酚为主,单用72例(92.3%),中位剂量0.64 mg/kg [IQR 0.53, 0.81];无患者需气管插管,4例(5.1%)需球囊面罩通气。
- 11例(14%)出现收缩压一过性低于90 mmHg,仅发生于使用丙泊酚者;3例低血压患者接受至少500 cc生理盐水补液。
- 收缩压<90 mmHg在较低剂量丙泊酚组更常见:平均剂量0.51 mg/kg [95%CI 0.34, 0.68] vs 较高剂量0.71 mg/kg [95%CI 0.65, 0.78],平均差0.21 [95%CI 0.19, 0.39]。
- 低血压组未记录到神经或心脏后遗症。
适用人群与场景
- 急诊科就诊的近期发作心房颤动或心房扑动患者,BMI>35(定义为III级和IV级肥胖),接受急诊直流电心脏电复律。
诊断标准与关键阈值
- 肥胖分级采用体重指数(BMI)定义:III级和IV级肥胖为BMI>35。
处置流程与药物剂量
- 镇静用药:丙泊酚单用72例(92.3%),中位剂量0.64 mg/kg [IQR 0.53, 0.81];丙泊酚0.56 mg/kg [IQR 0.28, 0.74]联合氯胺酮0.56 mg/kg [IQR 0.15, 1.66]用于4例(5.0%);氯胺酮单用0.64 mg/kg [IQR 0.38, 0.94]用于2例。
- 低血压处理:3例收缩压<90 mmHg的患者接受至少500 cc生理盐水补液。
红旗征与不能漏的情况
- 收缩压一过性低于90 mmHg(11例,14%),仅发生于使用丙泊酚者;低血压组未记录神经或心脏后遗症。
- 需球囊面罩通气(4例,5.1%);无患者需气管插管。
研究设计与关键结果
- 回顾性图表审查,78例BMI>35的III/IV级肥胖急诊房颤/房扑患者行直流电心脏电复律,平均体重117.6 kg [95%CI 112.5-112.9],平均BMI 39.9 kg/m² [95%CI 38.9-41.0]。
- 电复律成功(转为持续窦性心律)72例(92.3%),58例(74.5%)从急诊出院。
- 丙泊酚单用72例(92.3%),中位剂量0.64 mg/kg [IQR 0.53, 0.81];丙泊酚联合氯胺酮4例(5.0%);氯胺酮单用2例。
- 无患者需气管插管,4例(5.1%)需球囊面罩通气,11例(14%)出现收缩压一过性低于90 mmHg,仅见于使用丙泊酚者。
- 收缩压<90 mmHg在较低剂量丙泊酚组更常见:平均剂量0.51 mg/kg [95%CI 0.34, 0.68] vs 较高剂量0.71 mg/kg [95%CI 0.65, 0.78],平均差0.21 [95%CI 0.19, 0.39]。
- 低血压组未记录神经或心脏后遗症。
证据类型、等级与局限
- 证据类型:回顾性图表审查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于BMI>35的III/IV级肥胖急诊房颤/房扑患者,急诊直流电心脏电复律成功率高(92.3%),多数可出院(74.5%)。
- 丙泊酚镇静下收缩压一过性低于90 mmHg的发生率为14%,仅见于使用丙泊酚者,但未记录神经或心脏后遗症。
- 作者结论认为急诊直流电心脏电复律安全有效。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Direct current cardioversion (DCCV) of recent onset atrial fibrillation or flutter (AF) is an accepted therapy for ED patients with this arrhythmia. Patient obesity lowers the success rate of this procedure while increasing the risks of procedural sedation (PS).
METHODS: A retrospective chart review was conducted of patients with Body Mass Index (BMI) defined Class III and IV obesity (BMI >35) undergoing ED performed DCCV for AF. Abstracted chart data included, Procedural Sedation medication, success of conversion to sustained sinus rhythm, ED disposition, airway complications defined as the need for endotracheal intubation (ETI) or hypotension defined as systolic blood pressure (SBP) < 90 mmHg.
RESULTS: A total of 78 patients met study inclusion criteria with a mean weight of 117.6 kg [95 % C·I. 112.5-112.9] and mean BMI of 39.9 kg [95 % C·I. 38.9-41.0]. DCCV was successful in 72 (92.3 %) of patients with 58 (74.5 %) discharged from the ED. Propofol, median dose 0.64 mg/kg [IQR = 0.53, 0.81] was the sedation agent alone for 72 (92.3 %) cases, propofol 0.56 mg/kg [IQR = 0.28, 0.74] plus ketamine 0.56 mg/kg [IQR = 0.15, 1.66] was used in 4 (5.0 %) and ketamine 0.64 mg/kg [IQR = 0.38, 0.94] alone in 2. No patient required ETI. Four patients (5.1 %) required a period of bag valve mask ventilation. Eleven patients (14 %) experienced a transient decrease in systolic blood pressure below 90 mm hg. Three hypotensive patients received a normal saline fluid bonus of at least 500 cc. Hypotension only occurred in patients receiving propofol. A SBP < 90 mmHg was more common in patients receiving a lower dose of propofol mean dose 0.51 mg/kg [95 % C.I. 0.34, 0.68] than a higher dose 0.71 mg/kg [95 % C.I. 0.65, 0.78], mean difference 0.21 [95 % C.I. 0.19, 0.39]. No neurologic or cardiac sequelae were recorded in the hypotensive group.
CONCLUSION: Emergency Department DCCV of recent onset AF is safe and effective.
参考来源
- Sacchetti A, Glasofer A, Le K, et al. Emergency department cardioversion of atrial fibrillation or flutter in class III and IV obese patients is safe and effective. Am J Emerg Med. 2025. PMID: 40834834. doi:10.1016/j.ajem.2025.08.024
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。